SCHEMBL26131044

SCHEMBL26131044

CN(C)CC1CN(c2ncc(Br)cc2[N+](=O)[O-])C1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 2/20 0.40
▸ MAPK1 P28482 1/20 0.40
▸ HTT P42858 1/20 0.40
▸ CYP2C9 P11712 3/20 0.35
▸ CYP3A4 P08684 1/20 0.35
▸ CYP2D6 P10635 1/20 0.35
▸ PRKCQ Q04759 1/20 0.35
▸ OPRK1 P41145 7/20 0.35
▸ USP14 P54578 1/20 0.34
▸ SMN1; SMN2 Q16637 1/20 0.33
▸ JAK2 O60674 1/20 0.32
▸ JAK1 P23458 1/20 0.32
▸ JAK3 P52333 1/20 0.32
▸ HRH4 Q9H3N8 1/20 0.32
▸ MEN1 O00255 1/20 0.32
▸ KMT2A Q03164 1/20 0.32
▸ CYP1A2 P05177 2/20 0.32
▸ CYP2C19 P33261 2/20 0.32
▸ CCR6 P51684 1/20 0.32
▸ CCR4 P51679 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29969938 1.00 ALDH1A1 (0.40) ALDH1A1MAPK1HTTCYP2C9CYP3A4
SCHEMBL26131943 0.88 ALDH1A1 (0.44) ALDH1A1MAPK1HTTCYP2C9CYP3A4
SCHEMBL29968881 0.88 ALDH1A1 (0.44) ALDH1A1MAPK1HTTCYP2C9CYP3A4
SCHEMBL22941968 0.84 ALDH1A1 (0.43) ALDH1A1MAPK1HTTCYP2C9OPRK1
SCHEMBL26127971 0.82 ALDH1A1 (0.40) ALDH1A1MAPK1HTTCYP2C9OPRK1
SCHEMBL29969671 0.82 ALDH1A1 (0.40) ALDH1A1MAPK1HTTCYP2C9OPRK1
SCHEMBL26130281 0.79 ALDH1A1 (0.39) ALDH1A1MAPK1HTTOPRK1JAK2
SCHEMBL21513232 0.78 OPRK1 (0.33) HTTOPRK1JAK2JAK1JAK3
SCHEMBL29968653 0.78 ALDH1A1 (0.36) ALDH1A1MAPK1HTTOPRK1JAK2
SCHEMBL26130136 0.78 ALDH1A1 (0.36) ALDH1A1MAPK1HTTOPRK1JAK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4327877-A2 DUAL ATM AND DNA-PK INHIBITORS FOR USE IN ANTI-TUMOR THERAPY XRad Therapeutics, Inc. (US) 2024-02-28 — — EP disclosed
EP-3784671-B1 DUAL ATM AND DNA-PK INHIBITORS FOR USE IN ANTI-TUMOR THERAPY XRAD THERAPEUTICS INC (US) 2023-10-11 — — EP disclosed
Send feedback